Savara, Inc. (SVRA)
4.81
-0.24
(-4.66%)
USD |
NASDAQ |
Oct 02, 16:00
4.815
0.00 (0.00%)
After-Hours: 20:00
Savara Price : 4.81 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 5.10 | 5.16 | 4.765 | 4.81 | 2.653M |
| Oct 01, 2026 | 5.15 | 5.24 | 5.03 | 5.045 | 2.550M |
| Sep 30, 2026 | 5.15 | 5.24 | 5.05 | 5.16 | 6.052M |
| Sep 29, 2026 | 5.07 | 5.19 | 5.00 | 5.08 | 2.035M |
| Sep 28, 2026 | 4.97 | 5.155 | 4.86 | 5.07 | 4.372M |
| Sep 25, 2026 | 5.08 | 5.18 | 4.87 | 5.00 | 2.452M |
| Sep 24, 2026 | 5.03 | 5.085 | 4.884 | 5.07 | 2.500M |
| Sep 23, 2026 | 5.30 | 5.34 | 4.90 | 5.00 | 3.354M |
| Sep 22, 2026 | 5.52 | 5.525 | 5.29 | 5.30 | 1.414M |
| Sep 21, 2026 | 5.44 | 5.51 | 5.36 | 5.45 | 1.312M |
| Sep 18, 2026 | 5.42 | 5.47 | 5.305 | 5.37 | 2.182M |
| Sep 17, 2026 | 5.23 | 5.465 | 5.22 | 5.42 | 1.229M |
| Sep 16, 2026 | 5.29 | 5.351 | 5.105 | 5.13 | 1.127M |
| Sep 15, 2026 | 5.33 | 5.34 | 5.175 | 5.26 | 1.301M |
| Sep 14, 2026 | 5.33 | 5.43 | 5.28 | 5.34 | 1.310M |
| Sep 11, 2026 | 5.38 | 5.395 | 5.27 | 5.30 | 1.064M |
| Sep 10, 2026 | 5.34 | 5.46 | 5.24 | 5.32 | 1.525M |
| Sep 09, 2026 | 5.48 | 5.57 | 5.37 | 5.415 | 1.095M |
| Sep 08, 2026 | 5.27 | 5.63 | 5.26 | 5.53 | 1.661M |
| Sep 04, 2026 | 5.32 | 5.39 | 5.31 | 5.37 | 625457.0 |
| Sep 03, 2026 | 5.52 | 5.52 | 5.29 | 5.37 | 1.240M |
| Sep 02, 2026 | 5.47 | 5.56 | 5.365 | 5.46 | 1.217M |
| Sep 01, 2026 | 5.32 | 5.405 | 5.29 | 5.35 | 1.042M |
| Aug 31, 2026 | 5.25 | 5.44 | 5.21 | 5.39 | 1.959M |
| Aug 28, 2026 | 5.48 | 5.51 | 5.25 | 5.26 | 1.336M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 144.74 |
| Insmed, Inc. | 111.12 |
| United Therapeutics Corp. | 541.70 |
| Vertex Pharmaceuticals, Inc. | 504.73 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
Price Related Metrics
| PEG Ratio | -0.6729 |
| Price to Book Value | 6.877 |
| Earnings Yield | -11.99% |
| Market Cap | 987.97M |
| PEGY Ratio | -0.6729 |